Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) announced plans to participate in four national benefits conferences during June, where the company will discuss its innovative approaches to cardiovascular disease prevention, risk assessment, and cost management. The initiative targets employers and benefits organizations seeking to curb rising healthcare costs linked to cardiovascular disease, which remains one of the most expensive health conditions in the United States.
According to the American Heart Association, direct cardiovascular healthcare costs accounted for approximately 11% of all U.S. healthcare expenditures in 2020–2021, more than any other major diagnostic group. A single heart attack or major cardiovascular event can have consequences that extend beyond a patient’s health, affecting employers, insurers, and healthcare systems through higher medical costs, lost productivity, and long-term care expenses.
Cardio Diagnostics has developed a suite of solutions designed to provide earlier identification of cardiovascular risk and enable more targeted interventions and preventive care. By engaging directly with stakeholders at these conferences, the company aims to help employers tackle cardiovascular risk and the associated financial burden. The conferences provide a platform for the company to demonstrate how its technology can identify risk earlier, potentially reducing the incidence of costly events.
The company’s presence at these events underscores the growing focus on preventive health strategies within the employer benefits space. As healthcare costs continue to rise, organizations responsible for employee benefits are actively seeking new strategies to identify risk earlier and improve outcomes. Cardio Diagnostics’ solutions align with this trend, offering tools that could lead to more efficient allocation of healthcare resources and better health outcomes for employees.
Investors can find the latest news and updates relating to Cardio Diagnostics in the company’s newsroom at https://nnw.fm/CDIO.
